Immune-related chemotactic factors were found in acute coronary syndromes by bioinformatics

Molecular Biology Reports

Volumn 41, Issue 7, 2014, Pages 4389-4395

  Zhang, Lei ^a   Li, Jian ^a   Liang, Aibin ^a   Liu, Yang ^a   Deng, Bing ^b   Wang, Hao ^a  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Acute coronary syndrome; Differentially expressed gene; Functional enrichment analysis; Pathway analysis; Small molecule drug

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOTACTIC FACTOR; CXCL11 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; INTERLEUKIN 10; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; CARDIOTONIC AGENT; CHEMOKINE; DANAZOL; MIMOSINE; MOLECULAR LIBRARY;

ACUTE CORONARY SYNDROME; ARTICLE; BIOINFORMATICS; CCL2 GENE; CCL20 GENE; CCL22 GENE; CCL7 GENE; CCL8 GENE; CCR1 GENE; CXCL11 GENE; CXCL2 GENE; CXCL3 GENE; DATA ANALYSIS; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; IL10 GENE; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE; THROMBUS; UPREGULATION; ANTAGONISTS AND INHIBITORS; BIOLOGY; CASE CONTROL STUDY; DRUG DATABASE; GENE EXPRESSION PROFILING; GENETIC DATABASE; GENETICS; HUMAN; IMMUNOLOGY; MOLECULAR LIBRARY; PATHOLOGY; PHARMACOLOGY; PROTEIN ANALYSIS;

ACUTE CORONARY SYNDROME; CARDIOTONIC AGENTS; CASE-CONTROL STUDIES; CHEMOKINES; COMPUTATIONAL BIOLOGY; DANAZOL; DATABASES, GENETIC; DATABASES, PHARMACEUTICAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MIMOSINE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN INTERACTION MAPPING; SMALL MOLECULE LIBRARIES;

EID: 84903381948     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3310-7     Document Type: Article

References (51)

1. Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO, Gibbons RJ, Alpert JP, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO (2001) ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines) - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol 37(8):2215-2239
2. Davies MJ (1996) Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 94(8):2013-2020
3. Falk E, Shah PK, Fuster V (1995) Coronary plaque disruption. Circulation 92(3):657-671
4. Hamm CW, Braunwald E (2000) A classification of unstable angina revisited. Circulation 102(1):118-122 (Pubitemid 30430562)
5. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW (2000) Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 343(13):915-922. doi:10.1056/NEJM200009283431303
6. Januzzi JL Jr, Buros J, Cannon CP (2005) Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trial. Clin Cardiol 28(5):238-242 (Pubitemid 40676667)
7. Zebrack JS, Anderson JL (2002) The role of inflammation and infection in the pathogenesis and evolution of coronary artery disease. Curr Cardiol Rep 4(4):278-288
8. Libby P (1995) Molecular bases of the acute coronary syndromes. Circulation 91(11):2844-2850
9. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, Humphries S (1991) Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA 88(18):8154-8158 (Pubitemid 21915315)
10. Galis ZS, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94(6):2493-2503. doi:10.1172/JCI117619 (Pubitemid 24379627)
11. Nikkari ST, O'Brien KD, Ferguson M, Hatsukami T, Welgus HG, Alpers CE, Clowes AW (1995) Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 92(6):1393-1398
12. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J (1993) Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69(5):377-381
13. van der Wal AC, Becker AE, van der Loos CM, Das PK (1994) Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89(1):36-44
14. Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, Virmani R (1996) Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 93(7):1354-1363 (Pubitemid 26099346)
15. Bevilacqua MP, Schleef RR, Gimbrone MA Jr, Loskutoff DJ (1986) Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J Clin Invest 78(2):587-591. doi:10.1172/JCI112613 (Pubitemid 16074099)
16. Håkanson M, Kobel S, Lutolf MP, Textor M, Cukierman E, Charnley M (2012) Controlled breast cancer microarrays for the deconvolution of cellular multilayering and density effects upon drug responses. PLoS ONE 7(6):e40141
17. Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discovery 5(3):219-234 (Pubitemid 43336035)
18. Chan T-M, Harn H-J, Chiou T-W, Lin S-Z (2013) Developing new small molecular drugs for prostate cancer therapy. J Cancer Ther 4:86-90
19. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D, Altman RB (2001) Missing value estimation methods for DNA microarrays. Bioinformatics 17(6):520-525 (Pubitemid 32600498)
20. Fujita A, Sato JR, Rodrigues Lde O, Ferreira CE, Sogayar MC (2006) Evaluating different methods of microarray data normalization. BMC Bioinformatics 7:469. doi:10.1186/1471-2105-7-469
21. Smyth GK (2005) Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W (eds) Bioinformatics and computational biology solutions using R and Bioconductor. Springer, New York, pp 397-420. doi:10.1007/0-387-29362-0-23
22. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol) 57(1):289-300. doi:10.2307/2346101
23. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, Jensen LJ, von Mering C (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39(Database issue):D561-D568. doi:10.1093/nar/gkq973
24. Zhang B, Kirov S, Snoddy J (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33(Web Server issue):W741-W748. doi:10.1093/nar/gki475
25. Duncan D, Prodduturi N, Zhang B (2010) WebGestalt2: an updated and expanded version of the Web-based Gene Set Analysis Toolkit. BMC Bioinformatics 11(Suppl 4):P10. doi:10.1186/1471-2105-11-S4-P10
26. Hosack D, Dennis G, Sherman B, Lane C, Lempicki R (2003) Identifying biological themes within lists of genes with EASE. Genome Biol 4(10):R70. doi:10.1186/gb-2003-4-10-r70
27. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34(Database issue):D668-D672. doi:10.1093/nar/gkj067
28. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36(Database issue):D901-D906. doi:10.1093/nar/gkm958 (Pubitemid 351149842)
29. Kubica J, Kozinski M, Krzewina-Kowalska A, Zbikowska-Gotz M, Dymek G, Sukiennik A, Piasecki R, Bogdan M, Grzesk G, Chojnicki M, Dziedziczko A, Sypniewska G (2005) Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions. Int J Mol Med 16(1):173-180
30. Meng F, Lowell CA (1997) Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Srcfamily kinases Hck, Fgr, and Lyn. J Exp Med 185(9):1661-1670 (Pubitemid 27203262)
31. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R (1994) Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Intensive Care Med 20(3):225-232 (Pubitemid 24088590)
32. Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354(6):610-621. doi:10.1056/NEJMra052723 (Pubitemid 43209108)
33. Coll B, Alonso-Villaverde C, Joven J (2007) Monocyte chemoattractant protein-1 and atherosclerosis: is there room for an additional biomarker? Clin Chim Acta 383(1-2):21-29. doi:10.1016/j.cca.2007.04.019 (Pubitemid 47018251)
34. Combadiere C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, Merval R, Proudfoot A, Tedgui A, Mallat Z (2008) Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117(13):1649-1657. doi:10.1161/CIRCULATIONAHA.107.745091 (Pubitemid 351482605)
35. Paoletti S, Petkovic V, Sebastiani S, Danelon MG, Uguccioni M, Gerber BO (2005) A rich chemokine environment strongly enhances leukocyte migration and activities. Blood 105(9):3405-3412. doi:10.1182/blood-2004-04-1648 (Pubitemid 40628179)
36. Crown SE, Yu Y, Sweeney MD, Leary JA, Handel TM (2006) Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding. J Biol Chem 281(35):25438-25446. doi:10.1074/jbc.M601518200 (Pubitemid 44401932)
37. Braunersreuther V, Mach F, Steffens S (2007) The specific role of chemokines in atherosclerosis. Thromb Haemost 97(5):714-721 (Pubitemid 46804314)
38. Ardigo D, Assimes TL, Fortmann SP,GoAS, Hlatky M,Hytopoulos E, Iribarren C, Tsao PS, Tabibiazar R, Quertermous T (2007) Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease. Physiol Genomics 31(3):402-409. doi:10.1152/physiolgenomics.00104.2007 (Pubitemid 350127780)
39. Kimura S, Tanimoto A, Wang KY, Shimajiri S, Guo X, Tasaki T, Yamada S, Sasaguri Y (2012) Expression of macrophage-derived chemokine (CCL22) in atherosclerosis and regulation by histamine via the H2 receptor. Pathol Int 62(10):675-683. doi:10.1111/j.1440-1827.2012.02854.x
40. Jabs A, Okamoto E, Vinten-Johansen J, Bauriedel G, Wilcox JN (2007) Sequential patterns of chemokine- and chemokine receptor- synthesis following vessel wall injury in porcine coronary arteries. Atherosclerosis 192(1):75-84. doi:10.1016/j.atherosclerosis.2006.05.050 (Pubitemid 46602307)
41. Tabas I (2010) The role of endoplasmic reticulum stress in the progression of atherosclerosis. Circ Res 107(7):839-850. doi:10.1161/CIRCRESAHA. 110.224766
42. Castillo L, Rohatgi A, Ayers CR, Owens AW, Das SR, Khera A, McGuire DK, de Lemos JA (2010) Associations of four circulating chemokines with multiple atherosclerosis phenotypes in a large population-based sample: results from the dallas heart study. J Interferon Cytokine Res 30(5):339-347. doi:10.1089/jir.2009.0045
43. Tabibiazar R, Wagner RA, Deng A, Tsao PS, Quertermous T (2006) Proteomic profiles of serum inflammatory markers accurately predict atherosclerosis in mice. Physiol Genomics 25(2):194-202. doi:10.1152/physiolgenomics.00240.2005
44. Potteaux S, Combadiere C, Esposito B, Casanova S, Merval R, Ardouin P, Gao JL, Murphy PM, Tedgui A, Mallat Z (2005) Chemokine receptor CCR1 disruption in bone marrow cells enhances atherosclerotic lesion development and inflammation in mice. Mol Med 11(1-12):16-20. doi:10.2119/2005-00028.Potteaux
45. Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O (2010) Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 122(18):1837-1845. doi:10.1161/CIRCULATIONAHA.110.961714
46. Souza DG, Teixeira MM (2005) The balance between the production of tumor necrosis factor-alpha and interleukin-10 determines tissue injury and lethality during intestinal ischemia and reperfusion. Mem Inst Oswaldo Cruz 100(Suppl 1):59-66 (Pubitemid 40685441)
47. Frydas S, Papaioannou N, Papazahariadou M, Hatzistilianou M, Karagouni E, Trakatelli M, Brellou G, Petrarca C, Castellani ML, Conti P, Riccioni G, Patruno A, Grilli A (2005) Inhibition of MCP-1 and MIP-2 chemokines in murine trichinellosis: effect of the anti-inflammatory compound L-mimosine. Int J Immunopathol Pharmacol 18(1):85-94
48. Jolicoeur C, Lemay A, Akoum A (2001) Comparative effect of danazol and a GnRH agonist on monocyte chemotactic protein-1 expression by endometriotic cells. Am J Reprod Immunol 45(2):86-93 (Pubitemid 32111903)
49. Crook D, Sidhu M, Seed M, O'Donnell M, Stevenson JC (1992) Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid. Atherosclerosis 92(1):41-47
50. Krude T (1999) Mimosine arrests proliferating human cells before onset of DNA replication in a dose-dependent manner. Exp Cell Res 247(1):148-159
51. Crowe B, Poynter JA, Manukyan MC, Wang Y, Brewster BD, Herrmann JL, Abarbanell AM, Weil BR, Meldrum DR (2011) Pretreatment with intracoronary mimosine improves postischemic myocardial functional recovery. Surgery 150(2):191-196